Skip to main content
SMFM 2024 Pregnancy Meeting Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Additional registration fee required
Additional registration fee required
Faculty have requested this content not be shared on social media
Faculty have requested this content not be shared on social media
CME Credit Offered
CME Credit Offered
Poster Icons
Foundation Awardee
Foundation Awardee
No Social Media
No Social Media
Back

Industry Supported Learning

Championing Maternal Health: Nobel Prize-Winning Discoveries Transforming Preeclampsia

Monday, February 12, 2024
7:00 AM – 8:00 AM  
Location: Cherry Blossom Ballroom, Ballroom Level
CE: 0

Sponsored By 
CE Credits: 0
CME Credits: 0
Ultrasound Credits: 0

    Industry Session Presenter(s)

  • AA

    Allison August

    Chief Medical Officer
    Comanche Biopharma

    I have nothing relevant to disclose for this role and/or disclosures are not required to be reported for this non-CME activity.

  • Maged Costantine, MD (he/him/his)

    Director MFM
    The Ohio State University
    Columbus, OH, United States

    I have nothing relevant to disclose for this role and/or disclosures are not required to be reported for this non-CME activity.

  • Allyson Felix

    US Olympic Champion, Co-Founder and President
    Saysh

    I have nothing relevant to disclose for this role and/or disclosures are not required to be reported for this non-CME activity.

  • TM

    Thomas McElrath, MD,PhD

    Brigham and Women's Hospital
    Boston, MA, United States

    I have nothing relevant to disclose for this role and/or disclosures are not required to be reported for this non-CME activity.

  • MM

    Melissa Moore

    Chief Scientific Officer Emeritus, Moderna, Professor & Entrepreneur
    UMass Medical School

    I have nothing relevant to disclose for this role and/or disclosures are not required to be reported for this non-CME activity.

This independent presentation is not part of the official program as planned by the SMFM Pregnancy Meeting™ Program Committee. The content of this session is not endorsed by or recommended by SMFM.

This thought-provoking symposium on preeclampsia convenes leading experts: Olympic champion and maternal health advocate Allyson Felix; Thomas McElrath, a renowned figure in translational medicine in pregnancy; Maged Costantine, a distinguished maternal-fetal medicine specialist and researcher; and Melissa J. Moore, a respected authority in RNA science. Allison August, Chief Medical Officer of Comanche Biopharma, will moderate the event.

The program is designed to deepen the understanding of preeclampsia's complexities among clinicians. It will facilitate a scientific exchange on the latest research and scientific advancements, aiming to foster collaborative efforts in advancing solutions to address this urgent maternal health issue.

Learning Objectives:

  • Comprehend the role of sFlt-1 in the pathophysiology of preeclampsia and the implications for diagnosis and treatment.
  • Recognize the value of the available diagnostic tests for early detection and monitoring of preeclampsia.
  • Appreciate the clinician's perspective in using the diagnostic test to diagnose and manage preeclampsia and optimizing patient care.
  • Understand how siRNA therapeutics work and the potential of an siRNA therapeutic as a treatment option for preeclampsia.
  • Be aware of the patient's perspective and the impacts of preeclampsia.